Format

Send to

Choose Destination
Epigenomics. 2015;7(2):321-30. doi: 10.2217/epi.14.60.

Histone methylations in heart development, congenital and adult heart diseases.

Author information

1
Department of Internal Medicine-Cardiology Division & Molecular Biology, UT Southwestern Medical Center, 6000 Harry Hines Blvd, Dallas, TX, 75350, USA.

Abstract

Heart development comprises myocyte specification, differentiation and cardiac morphogenesis. These processes are regulated by a group of core cardiac transcription factors in a coordinated temporal and spatial manner. Histone methylation is an emerging epigenetic mechanism for regulating gene transcription. Interplay among cardiac transcription factors and histone lysine modifiers plays important role in heart development. Aberrant expression and mutation of the histone lysine modifiers during development and in adult life can cause either embryonic lethality or congenital heart diseases, and influences the response of adult hearts to pathological stresses. In this review, we describe current body of literature on the role of several common histone methylations and their modifying enzymes in heart development, congenital and adult heart diseases.

KEYWORDS:

cardiac hypertrophy; congenital heart disease; demethylase; epigenetics; heart development; histone; methyltransferase

PMID:
25942538
PMCID:
PMC4451103
DOI:
10.2217/epi.14.60
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Atypon Icon for PubMed Central
Loading ...
Support Center